Canada’s federal government has reintroduced to Parliament proposed changes to drug and patent laws that will make it easier for developing countries to obtain cheaper generic drugs.
The Court of Appeals for the Federal Circuit has vacated a lower court's ruling in Gemstar-TV Guide and SuperGuide's lawsuit against satellite broadcaster EchoStar Communications over patents for on-screen program guides.
International law firm Shaw Pittman has hired Steven E. Adkins, a seasoned patent attorney with broad experience at the International Trade Commission, as a partner in its litigation and intellectual property practice.
China’s top battery maker and rival Energizer Holdings have signed a cross-licensing agreement, ending a dispute at the U.S. International Trade Commission.
Sughrue Mion, PLLC, one of the largest intellectual property boutiques in the U.S., elected six of its attorneys to the partnership, the firm said Monday.
Seasoned international trade and intellectual property attorney Charles Schill has joined national law firm Steptoe & Johnson LLP's Washington office as a partner.
Once again, Brazil's government is playing hardball in its efforts to get deep discounts on anti-HIV drugs.
Wockhardt becomes the first domestic Indian drug maker to secure an exclusive marketing right as the government grants an EMR for its topical anti-bacterial drug Nadoxin.
India’s government introduced its patent bill ahead of schedule, seeking to bring the country into compliance with its international obligations regarding intellectual property rights by 2005.
Indian drug companies are lobbying the government for an exemption from patent infringement provisions in amendments to the country’s patent law for drugs already in the market.
Government approves introduction of bills aimed at securing TRIPS compliance and stiffen penalties for drug counterfeiting.
Arizona-based chip equipment maker seeks to block importation of Malaysian rival's products.
The European Parliament adopts sweeping new legislation aimed at standardizing regulatory data protection for drugs across the European Union.
F. Leslie Bessenger, III, Houtan K. Esfahani, Esther H. Lim, Michael A. Morin, Erik R. Puknys, and Douglas A. Rettew will assume their new positions on January 1, 2004.
Similar suits against 3com, Agere Systems, Lucent Technologies and U.S. Robotics are still proceeding.
Brazilian government continues to play hardball with HIV/AIDS drug makers after winning record discount from Bristol-Myers Squibb last month.
Bill would extend pharma patents but would leave rules on compulsory licensing and patentability intact, sources say.
International Trade Commission cites federal court decision that found technology did not violate the Digital Millennium Copyright Act.
Senior officials meet to discuss growing problem as U.S., Japanese and European automakers complain their product designs are being copied.
In a policy reversal, India’s government is expected to propose data protection for a period of three to five years for pharmaceutical inventors.